GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Intelligent Bio Solutions Inc (NAS:INBS) » Definitions » Piotroski F-Score

Intelligent Bio Solutions (Intelligent Bio Solutions) Piotroski F-Score : 3 (As of May. 11, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Intelligent Bio Solutions Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Intelligent Bio Solutions has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Intelligent Bio Solutions's Piotroski F-Score or its related term are showing as below:

INBS' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 5
Current: 3

During the past 7 years, the highest Piotroski F-Score of Intelligent Bio Solutions was 5. The lowest was 2. And the median was 3.


Intelligent Bio Solutions Piotroski F-Score Historical Data

The historical data trend for Intelligent Bio Solutions's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Bio Solutions Piotroski F-Score Chart

Intelligent Bio Solutions Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Piotroski F-Score
Get a 7-Day Free Trial N/A N/A 2.00 3.00 3.00

Intelligent Bio Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.00 3.00 3.00 3.00

Competitive Comparison of Intelligent Bio Solutions's Piotroski F-Score

For the Medical Devices subindustry, Intelligent Bio Solutions's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelligent Bio Solutions's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Intelligent Bio Solutions's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -6.344 + -2.659 + -2.425 + -1.97 = $-13.40 Mil.
Cash Flow from Operations was -2.518 + -0.584 + -1.312 + -2.869 = $-7.28 Mil.
Revenue was 0.457 + 0.443 + 0.796 + 0.764 = $2.46 Mil.
Gross Profit was 0.033 + 0.05 + 0.232 + 0.199 = $0.51 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(18.048 + 10.669 + 10.355 + 8.7 + 8.827) / 5 = $11.3198 Mil.
Total Assets at the begining of this year (Dec22) was $18.05 Mil.
Long-Term Debt & Capital Lease Obligation was $0.46 Mil.
Total Current Assets was $2.95 Mil.
Total Current Liabilities was $5.18 Mil.
Net Income was -1.335 + -2.078 + -1.208 + -0.421 = $-5.04 Mil.

Revenue was 0 + 0 + 0 + 0.357 = $0.36 Mil.
Gross Profit was 0 + 0 + 0 + 0.244 = $0.24 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(15.236 + 14.359 + 12.352 + 10.16 + 18.048) / 5 = $14.031 Mil.
Total Assets at the begining of last year (Dec21) was $15.24 Mil.
Long-Term Debt & Capital Lease Obligation was $1.39 Mil.
Total Current Assets was $6.38 Mil.
Total Current Liabilities was $4.82 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Intelligent Bio Solutions's current Net Income (TTM) was -13.40. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Intelligent Bio Solutions's current Cash Flow from Operations (TTM) was -7.28. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-13.398/18.048
=-0.74235372

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-5.042/15.236
=-0.33092675

Intelligent Bio Solutions's return on assets of this year was -0.74235372. Intelligent Bio Solutions's return on assets of last year was -0.33092675. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Intelligent Bio Solutions's current Net Income (TTM) was -13.40. Intelligent Bio Solutions's current Cash Flow from Operations (TTM) was -7.28. ==> -7.28 > -13.40 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0.46/11.3198
=0.04063676

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=1.388/14.031
=0.09892381

Intelligent Bio Solutions's gearing of this year was 0.04063676. Intelligent Bio Solutions's gearing of last year was 0.09892381. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=2.945/5.183
=0.56820374

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=6.378/4.815
=1.32461059

Intelligent Bio Solutions's current ratio of this year was 0.56820374. Intelligent Bio Solutions's current ratio of last year was 1.32461059. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Intelligent Bio Solutions's number of shares in issue this year was 0.079. Intelligent Bio Solutions's number of shares in issue last year was 0.006. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.514/2.46
=0.20894309

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.244/0.357
=0.68347339

Intelligent Bio Solutions's gross margin of this year was 0.20894309. Intelligent Bio Solutions's gross margin of last year was 0.68347339. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=2.46/18.048
=0.13630319

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=0.357/15.236
=0.02343135

Intelligent Bio Solutions's asset turnover of this year was 0.13630319. Intelligent Bio Solutions's asset turnover of last year was 0.02343135. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Intelligent Bio Solutions has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Intelligent Bio Solutions  (NAS:INBS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Intelligent Bio Solutions Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Intelligent Bio Solutions's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelligent Bio Solutions (Intelligent Bio Solutions) Business Description

Traded in Other Exchanges
Address
57th Street, 142 West, 11th Floor, New York, NY, USA, 10019
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana.
Executives
Harry Simeonidis director, officer: CEO, President 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017
Foundation Ma-ran 10 percent owner 1908 CLIFF VALLEY WAY NE, ATLANTA GA 30329
Gary W. Rollins Foundation 10 percent owner 1908 CLIFF VALLEY WAY NE, ATLANTA GA 30329
David A Jenkins director P.O. BOX 682838, PARK CITY UT 84068
Jason Isenberg director 1908 CLIFF VALLEY WAY NE, ATLANTA GA 30329
Spiro Kevin Sakiris officer: Chief Financial Officer 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017
Life Science Biosensor Diagnostics Pty Ltd 10 percent owner LEVEL 9, 85 CASTLEREAGH STREET, SYDNEY C3 2000
Tom Parmakellis director 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017
Victoria Gavrilenko director 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017
Christopher Towers director 1981 MARCUS AVENUE, SUITE 130, LAKE SUCCESS NY 11042
Lawrence B Fisher director C/0 FINANCIAL FEDERAL CORP, 733 THIRD AVENUE, NEW YORK NY 10017
Leonard Victor Kempler director 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017
George Margelis director 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017
Boyages Steven Constantine director 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017
Jonathan Scott Hurd director 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017

Intelligent Bio Solutions (Intelligent Bio Solutions) Headlines

From GuruFocus

Intelligent Bio Solutions Inc. Announces Reverse Stock Split

By sperokesalga sperokesalga 02-09-2023